SCHEMBL24896301

SCHEMBL24896301

CC1(C)CCC(c2ccc(Cl)cc2)=C(I)C1

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.44
PTGS1 P23219 4/20 0.44
BCL2L1 Q07817 1/20 0.41
BCL2 P10415 3/20 0.36
SLC6A3 Q01959 3/20 0.33
ALPL P05186 1/20 0.33
SLC6A2 P23975 1/20 0.33
ALDH1A1 P00352 2/20 0.32
USP2 O75604 1/20 0.32
PTK2B Q14289 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
HSD17B10 Q99714 1/20 0.32
BUB1 O43683 1/20 0.32
WRN Q14191 1/20 0.32
TP53 P04637 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19014652 0.81 PTGS2 (0.45) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL18011819 0.79 BCL2L1 (0.49) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL25215204 0.78 BCL2L1 (0.51) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL3420856 0.77 PTGS2 (0.53) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL3420849 0.77 PTGS2 (0.49) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL25067951 0.77 PTGS2 (0.42) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL10058349 0.77 BCL2L1 (0.50) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL24896307 0.77 PTGS2 (0.45) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL22428759 0.77 PTGS2 (0.42) PTGS2PTGS1BCL2L1BCL2SLC6A3
SCHEMBL21851539 0.76 PTGS2 (0.44) PTGS2PTGS1BCL2L1BCL2SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023288103-A1 METHODS FOR PREPARING LIPOSOMAL FORMULATIONS CELATOR PHARMACEUTICALS, INC. (US) 2023-01-19 WO disclosed
WO-2023288100-A1 LIPOSOMAL FORMULATIONS OF BCL INHIBITORS CELATOR PHARMACEUTICALS, INC. (US) 2023-01-19 WO disclosed